§ 13F · FUND PROFILE
SR One Capital Management, LP.
AUM · $1.0B (13F)Positions · 15Turnover · n/a · Q2Filed · Aug 12, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$207M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 12, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | MANE | Veradermics, Inc. | 2.40M | $295M | 28.4% | ±0% |
| 2 | ZBIO | Zenas BioPharma, Inc | 5.04M | $128M | 12.3% | ±0% |
| 3 | CRSP | CRISPR Therapeutics AG | 2.04M | $111M | 10.7% | ±0% |
| 4 | AVLN | Avalyn Pharma, Inc | 3.31M | $109M | 10.5% | NEW |
| 5 | DSGN | Design Therapeutics, Inc. | 6.53M | $94M | 9.1% | ±0% |
| 6 | ODTX | Odyssey Therapeutics, Inc. | 3.79M | $71M | 6.8% | NEW |
| 7 | ALMS | Alumis Inc. | 1.96M | $55M | 5.3% | ±0% |
| 8 | ORIC | ORIC Pharmaceuticals, Inc. | 4.62M | $50M | 4.8% | +2% |
| 9 | MLYS | Mineralys Therapeutics Inc. | 1.56M | $42M | 4.1% | ±0% |
| 10 | SPRY | ARS Pharmaceuticals, Inc. | 4.01M | $32M | 3.1% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SR SIGNAL
AC read
SR One Capital Management, LP is a Other fund managing $1.0 billion in assets. The fund runs a focused portfolio of just 15 positions.
Read the full dossier →